ACTIVEScience

FDA approves Retatrutide by Dec 31, 2026

Name: Will the U.S. Food and Drug Administration (FDA) grant a full or conditional approval for Eli Lilly's retatrutide drug product for any use between market creation and December 31, 2026, 11:59 PM ET?
Start: 2026-04-08T11:45:41.325Z
End: 2026-12-31T00:00:00.000Z

Will the U.S. Food and Drug Administration (FDA) grant a full or conditional approval for Eli Lilly's retatrutide drug product for any use between market creation and December 31, 2026, 11:59 PM ET?

External market source

ACTIVE

YES11%

NO89%

Closes Dec 30, 2026, 7:00 PM ET